John D Morberg
CIK 1345964 · Chief Financial Officer · last filed 2024-01-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$587.9K
Companies
2
Total Filings
21
Lifetime Open-Market Net
$215.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LFCR | Chief Financial Officer | 125,617 | $4.68 | $587.9K | $0 | 2 | 2024-01-22 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Chief Financial Officer | 19,400 | $8.76 | $169.9K | $215.6K | 14 | 2022-08-15 |
Recent Filings · Page 2 of 3
21 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-20 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $22.1K | EDGAR |
| 2021-04-19 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $22.2K | EDGAR |
| 2021-04-16 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $22.0K | EDGAR |
| 2021-04-15 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $21.3K | EDGAR |
| 2021-04-13 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $20.4K | EDGAR |
| 2021-02-12 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +1,400 | $16.6K | EDGAR |
| 2021-02-11 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $23.3K | EDGAR |
| 2021-02-10 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $24.1K | EDGAR |
| 2021-02-09 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $21.9K | EDGAR |
| 2021-02-08 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Buy (P) | +2,000 | $21.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.